IFN-γ is also important in the innate antiviral immune response against hepatitis C. IFN-γ therapy has been unsuccessful in the treatment of chronic HCV infections that are resistant to IFN-α[25]–[27]. The gene discussed is IFNG; the disease is hepatitis C virus infection.